Welcome to our dedicated page for FULLER H B CO SEC filings (Ticker: FUL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on FULLER H B CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into FULLER H B CO's regulatory disclosures and financial reporting.
H.B. Fuller Company’s President and CEO, Celeste Beeks Mastin, reported an equity award and updated her holdings. On January 20, 2026, she received 9,533 Performance Stock Units, each representing a contingent right to receive one share of H.B. Fuller common stock, with vesting tied to return on invested capital at 80% of the target level on January 24, 2026. These units convert into common shares on a 1-for-1 basis.
After this award, she holds common stock directly and indirectly, including 16,119 shares of common stock held directly and 3,500 shares held indirectly through a revocable trust, as well as multiple employee stock options and restricted stock units that vest over time in three annual installments.
H.B. Fuller senior vice president, general counsel and corporate secretary Gregory O. Ogunsanya reported an award of 453 performance stock units on January 20, 2026 at a price of $0.0000 per unit. Each performance stock unit converts into one share of common stock and is scheduled to vest on October 4, 2026, based on return on invested capital performance at 80% of the target level.
Following this grant, Ogunsanya directly holds 5,564 shares of H.B. Fuller common stock, as well as multiple employee stock options and restricted stock units covering additional shares of common stock, all on a direct ownership basis.
H.B. Fuller executive Nathan D. Weaver reported an equity award and updated holdings in a Form 4 filing. On January 20, 2026, he acquired 1,271 performance stock units at an exercise price of $0.0000. Each unit represents a contingent right to receive one share of H.B. Fuller common stock on the vesting date of January 24, 2026, based on the company achieving 80% of its return on invested capital target.
Following the reported transactions, Weaver holds 9,552 shares of common stock directly, an amount that includes shares acquired through a dividend reinvestment plan. He also directly holds multiple fully vested employee stock options with various exercise prices and expiration dates, options that vest over three-year schedules, phantom units and restricted stock units that generally convert into common stock on a 1-for-1 basis and in some cases include dividend equivalent features.
H.B. Fuller VP and Corporate Controller Robert J. Martsching reported an equity award and updated his holdings. On January 20, 2026, he acquired 440 performance stock units at $0.0000 per unit, each representing a contingent right to receive one share of H.B. Fuller common stock. These units convert to stock on a 1-for-1 basis and are scheduled to vest on January 24, 2026, based on return on invested capital reaching 80% of the target level.
After the reported transaction, Martsching directly holds 15,283.307 shares of common stock, including amounts from a dividend reinvestment plan, along with multiple fully vested and time-vesting employee stock options, phantom units, and restricted stock units that also convert into common shares on a 1-for-1 basis.
H.B. Fuller Company executive Muhammad Shahbaz, Senior VP, BAS, reported equity holdings and a new incentive grant. On January 20, 2026, he received 1,337 performance stock units, each convertible into one share of common stock, with vesting on January 24, 2026. The filing notes this reflects achieving return on invested capital payout at 80% of the target level.
After the reported award, he directly beneficially owns 11,621 shares of common stock, including shares from a dividend reinvestment plan, as well as multiple employee stock options and restricted stock units, all held directly. The options have exercise prices ranging from $48.35 to $77.72 and expiration dates from January 24, 2030 to January 27, 2035. Restricted stock units and performance units convert on a 1-for-1 basis into common shares as they vest.
H.B. Fuller senior vice president Joao Magalhaes received 293 performance stock units on January 20, 2026. These units convert into H.B. Fuller common stock on a 1-for-1 basis and are scheduled to vest on January 24, 2026, based on the company achieving return on invested capital at 80% of the target level. Following this grant, he directly holds 3,285 shares of common stock plus multiple blocks of employee stock options with exercise prices between $45.05 and $77.72 and expiration dates ranging from January 2027 to February 2035, as well as several tranches of restricted stock units that also convert into common shares on a 1-for-1 basis. The filing reflects equity compensation and existing holdings, with no reported stock sales.
H.B. Fuller Executive Vice President James J. East reported an equity award and updated holdings. On January 20, 2026, he received 1,739 performance stock units, which convert into H.B. Fuller common stock on a 1-for-1 basis and are scheduled to vest on January 24, 2026. This amount reflects the company achieving its return on invested capital payout at 80% of the target level.
The Form 4 also lists his existing equity-based compensation, including multiple employee stock option grants, phantom units and restricted stock units that each convert into common shares on a 1-for-1 basis, with several awards vesting in three annual installments of 33%, 33% and 34%. East holds common stock directly and through a 401(k) plan, and the filing reflects an award and updated positions rather than any sale of shares.
H.B. Fuller senior vice president of global R&D, Du Xinyu, reported an equity award in company stock. On January 20, 2026, Du acquired 374 performance stock units, each convertible into one share of common stock and scheduled to vest on January 24, 2026, reflecting an 80% payout of a return-on-invested-capital target.
The filing also shows Du directly holds 2,254 shares of common stock, along with multiple employee stock options and restricted stock units covering several thousand additional shares at exercise prices between $48.35 and $77.72, with expiration dates running through 2035.
H.B. Fuller Executive VP and CFO John J. Corkrean received 2,943 performance stock units on January 20, 2026, at a stated price of $0.0000 per unit. These performance stock units convert into common stock on a 1-for-1 basis and represent a contingent right to receive H.B. Fuller common stock on the vesting date of January 24, 2026, based on return on invested capital payout at 80% of the target level. Following the reported transactions, he directly beneficially owned 54,646 shares of common stock and held a range of employee stock options, phantom units, and restricted stock units tied to H.B. Fuller common stock.
H.B. Fuller senior vice president Heather Campe, Sr. VP, International Growth, received 1,415 performance stock units on January 20, 2026. These units convert into H.B. Fuller common stock on a 1-for-1 basis and are scheduled to vest on January 24, 2026, reflecting achievement of return on invested capital at 80% of the target level.
After this grant, Campe directly holds 22,334.0782 shares of H.B. Fuller common stock, plus a range of vested and unvested employee stock options, restricted stock units, performance stock units and phantom units that each represent additional contingent rights to receive H.B. Fuller common shares under the company’s equity and deferred compensation plans.